Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Altria Group
MO
|
+$428M |
| 2 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$232M |
| 3 |
Grayscale Bitcoin Trust
GBTC
|
+$208M |
| 4 |
Morgan Stanley Direct Lending Fund
MSDL
|
+$201M |
| 5 |
Infosys
INFY
|
+$134M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$50.9B |
| 2 |
Apple
AAPL
|
+$38.9B |
| 3 |
Amazon
AMZN
|
+$26B |
| 4 |
NVIDIA
NVDA
|
+$23.3B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$17B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.37% |
| 2 | Financials | 10.81% |
| 3 | Healthcare | 9.76% |
| 4 | Consumer Discretionary | 9.08% |
| 5 | Industrials | 6.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
Genesco
GCO
$422M
| $9.98M | ﹤0.01% |
354,600
-157,696
| -31% | -$4.55M |
|
3327
Allogene Therapeutics
ALLO
$694M
| $9.98M | ﹤0.01% |
2,231,964
-1,103,688
| -33% | -$4.61M |
|
3328
PRA Group
PRAA
$755M
| $9.96M | ﹤0.01% |
381,944
-445,236
| -54% | -$10.9M |
|
3329
CareDx
CDNA
$2.42B
| $9.88M | ﹤0.01% |
932,617
-2,223,839
| -70% | -$22.2M |
|
3330
Viridian Therapeutics
VRDN
$2.67B
| $9.85M | ﹤0.01% |
562,541
-487,261
| -46% | -$9.45M |
|
3331
iShares Asia 50 ETF
AIA
$4.73B
| $9.85M | ﹤0.01% |
162,229
-171,893
| -51% | -$9.85M |
|
3332
Hartford Multifactor US Equity ETF
ROUS
$717M
| $9.85M | ﹤0.01% |
204,374
-44,738
| -18% | -$2.05M |
|
3333
Acco Brands
ACCO
$407M
| $9.84M | ﹤0.01% |
1,753,982
-1,641,040
| -48% | -$9.76M |
|
|
CBH
3334
DELISTED
Virtus Convertible & Income 2024 Target Term Fund
CBH
| $9.84M | ﹤0.01% |
1,117,495
-1,187,723
| -52% | -$10.4M |
|
3335
Unitil
UTL
$980M
| $9.82M | ﹤0.01% |
187,567
-206,985
| -52% | -$10.4M |
|
|
NVRO
3336
DELISTED
NEVRO CORP.
NVRO
| $9.8M | ﹤0.01% |
678,770
-340,562
| -33% | -$5.63M |
|
3337
Davis Select International ETF
DINT
$295M
| $9.8M | ﹤0.01% |
507,946
-705,290
| -58% | -$12.8M |
|
3338
Community Health Systems
CYH
$423M
| $9.79M | ﹤0.01% |
2,797,225
-4,219,887
| -60% | -$14.3M |
|
3339
Dimensional US Small Cap ETF
DFAS
$15.7B
| $9.78M | ﹤0.01% |
156,802
-102,886
| -40% | -$6.09M |
|
3340
BlackRock TCP Capital
TCPC
$345M
| $9.76M | ﹤0.01% |
935,461
+25,629
| +3% | +$283K |
|
|
CCC
3341
CCC Intelligent Solutions
CCC
$4.08B
| $9.72M | ﹤0.01% |
812,577
-303,387
| -27% | -$3.46M |
|
3342
Alkami Technology
ALKT
$2.11B
| $9.71M | ﹤0.01% |
395,191
-769,531
| -66% | -$18.9M |
|
3343
National Healthcare
NHC
$3.37B
| $9.71M | ﹤0.01% |
102,727
-96,047
| -48% | -$9.09M |
|
3344
First Trust Exchange-Traded Fund II First Trust International Equity Opportunities ETF
FPXI
$297M
| $9.69M | ﹤0.01% |
209,816
-206,260
| -50% | -$9.08M |
|
3345
Invesco AI and Next Gen Software ETF
IGPT
$1.21B
| $9.68M | ﹤0.01% |
213,976
-74,588
| -26% | -$3.16M |
|
|
PTVE
3346
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $9.66M | ﹤0.01% |
674,540
-6,923,290
| -91% | -$98.1M |
|
|
PCN
3347
PIMCO Corporate & Income Strategy Fund
PCN
$885M
| $9.66M | ﹤0.01% |
691,254
-642,180
| -48% | -$8.53M |
|
3348
Stevanato
STVN
$5.54B
| $9.65M | ﹤0.01% |
300,677
-272,405
| -48% | -$8.29M |
|
|
THR
3349
DELISTED
Thermon Group Holdings
THR
| $9.65M | ﹤0.01% |
294,931
-713,357
| -71% | -$21M |
|
3350
iShares iBonds 2026 Term High Yield and Income ETF
IBHF
$808M
| $9.62M | ﹤0.01% |
417,086
-416,148
| -50% | -$9.55M |
|
Similar funds
Morgan Stanley's Q1 2024 Portfolio in Review
As of Q1 2024, Morgan Stanley held 8,154 positions worth $1.25T, down 45% from $2.27T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Morgan Stanley withdrew a net $1.16T in Q1 2024, closing 332 positions and reducing 6,745 holdings. Its most notable exit was Mirati Therapeutics, Inc. Common Stock, an estimated $725M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Morgan Stanley opened a new position in Grayscale Bitcoin Trust worth $270M.
- Morgan Stanley's largest Q1 2024 buy was Grayscale Bitcoin Trust: 4,729,259 shares worth $270M.
- Morgan Stanley added most to Altria Group in Q1 2024, an estimated $428M increase.
- Morgan Stanley's biggest Q1 2024 reduction was Microsoft, cutting an estimated $50.9B.
- Morgan Stanley fully exited Mirati Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $725M.
- Morgan Stanley's ten largest holdings make up 19% of its $1.25T portfolio in Q1 2024.
- Morgan Stanley opened 333 new positions and closed 332 in Q1 2024.
- Morgan Stanley's portfolio value fell 45% quarter-over-quarter to $1.25T.
Based on Morgan Stanley's 13F filing for Q1 2024, filed 15 May 2024.